Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the complete record of transactions filed by Bradsher Neal C, Director. Director active across 1 company, notably Lineage Cell Therapeutics, Inc.. Cumulatively, 1 reports have been published. Activity tracked since 25 June 2021. The latest transaction was filed on 25 June 2021 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration
Neal C. Bradsher is a Board Member at Lineage Cell Therapeutics, Inc. He participates in overseeing the company's activities and strategic decision-making. His experience in the biopharmaceutical sector allows him to make significant contributions to the board.